Advertisement

Topics

Alfa Aesar Company Profile

02:55 EDT 21st June 2018 | BioPortfolio

Since 1963, scientists have relied on Alfa Aesar to supply high purity raw materials for a variety of research and development applications. Today, we are a recognized leader in the manufacture and supply of fine chemicals, metals and materials in sizes from gram-scale catalog items to semi-bulk and bulk production quantities. With over 27,000 standard catalog and bulk products in stock and the custom manufacturing capabilities to supply many more specialized items, we are a one-stop source for research chemicals, metals and materials.
Research chemicals for a broad range of applications
Our product line consists of a comprehensive range of inorganic, organic and organometallic compounds; pure metals and elements; precious metal compounds and catalysts; rare earths; analytical products; and select laboratory equipment. Backed by the global manufacturing network of Johnson Matthey and other key partnerships, we offer customers the highest quality and purity in fine chemical products. We are accustomed to supplying R and D laboratories in the pharmaceutical industry and the electronics industry, as well as academic institutions and many others. With most catalog items in stock for same-day shipment, and a friendly and knowledgeable staff, we provide customers with an unsurpassed level of service.

Location

26 Parkridge Road
Ward Hill
Massachusetts
1835
United States of America

Contact

Phone: 1-978-521-6300
Fax: 1-978-521-6350
Email: info@alfa.com


News Articles [167 Associated News Articles listed on BioPortfolio]

FDA Approves Retacrit (epoetin alfa-epbx) as First Epoetin Alfa Biosimilar for the Treatment of Anemia

May 15, 2018 -- The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney ...

Pfizer: FDA Oks First Epoetin Alfa Biosimilar For Treatment Of Anemia

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced the United States Food and Drug Administration approved Retacrit orepoetin alfa-epbx, a biosimilar to Epogen and Procrit (epoetin alfa), for a...

FDA Approves Pfizer’s Retacrit, the First Epoetin Alfa Biosimilar for the Treatment of Anemia

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) approved RETACRIT® (epoetin alfa-epbx), a biosimilar to Epogen...

FDA approves Pfizer’s epoetin alfa biosimilar Retacrit

FDA Approves Epoetin Alfa Biosimilar for Anemia

The FDA has approved epoetin alfa-epbx (Retacrit) as a biosimilar to epoetin alfa (Epogen/Procrit) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in p...

FDA approves Pfizer’s epoetin alfa biosimilar Retacrit to treat anemia

Pfizer’s Retacrit (epoetin alfa-epbx), a biosimilar to Amgen’s anemia drug Epogen/Procrit (epoetin alfa), has been approved by the US Food and Drug Administration (FDA) for all indications of the ...

Alfa Scientific's colorectal cancer immunoassay cleared by FDA

Alfa Scientific Designs' iFOB immunoassay fecal occult blood test received clearance from the FDA.  -More- 

FDA approves Pfizer's epoetin biosimilar Retacrit

The FDA has approved Pfizer’s biosimilar drug, Retacrit, a cut price competitor Amgen and Johnson & Johnson's bone marrow stimulating drug epoetin alfa. Retacrit (epoetin alfa-epbx), is a biosi...

Drugs and Medications [57 Associated Drugs and Medications listed on BioPortfolio]

Ribavirin [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin tablets. Ribavirin Tablets Initial U.S. Approval: 200...

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribasphere ribapak [Three Rivers Pharmaceuticals, LLC]

These highlights do not include all the information needed to use Ribasphere (ribavirin, USP) safely and effectively. See full prescribing information for Ribasphere (ribavirin, USP). Ribasphere (riba...

PubMed Articles [30 Associated PubMed Articles listed on BioPortfolio]

A strategy to reduce inflammation and anemia treatment's related costs in dialysis patients.

This is a post-hoc analysis evaluating erythropoiesis stimulating agents' (ESA) related costs while using an additional ultrafilter (Estorclean PLUS) to produce ultrapure dialysis water located within...

Changes in in vivo confocal microscopic findings of ocular surface squamous neoplasia during treatment with topical interferon alfa-2b.

To evaluate in vivo confocal microscopy (IVCM) findings of ocular surface squamous neoplasia (OSSN) during treatment with topical interferon alfa-2b (IFN alfa-2b).

Immune tolerance induction rescue with turoctocog-alfa in a poor risk haemophilia A inhibitor young child: the history of a success.

: The development of alloantibodies against the replacement of Factor VIII (FVIII) is the major complication in haemophilia A treatment. The gold standard to eradicate inhibitors is the immune toleran...

Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model.

Increasing use of factor Xa (FXa) inhibitors necessitates effective reversal agents to manage bleeding. Andexanet alfa, a novel modified recombinant human FXa, rapidly reverses the anticoagulation eff...

Thrombomodulin alfa attenuates the procoagulant effect and cytotoxicity of extracellular histones through the promotion of protein C activation.

Extracellular histones are reported to increase thrombin generation in the plasma and induce endothelial cell death in vitro. These effects of histones were suggested to involve histone-induced inhibi...

Clinical Trials [898 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Reduction and Viral Safety of IFN Alfa-2b XL + Ribavirin Versus PEG IFN Alfa-2b + Ribavirin in Patients With Chronic Hepatitis C Genotype 1

The purpose of this study is to confirm if IFN alfa-2b XL has a better antiviral activity and tolerability as compared with current marketed reference, while combined with ribavirin, in a ...

Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia

The purpose of this study is to evaluate the cost-effectiveness of epoetin alfa compared with darbepoetin alfa in the treatment of anemia in adults receiving chemotherapy for cancer. Epoe...

PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients

The purpose of this study is to demonstrate that once every-2-weeks and once every-4-weeks treatment with epoetin alfa, a drug that increases red blood cell production, in patients with an...

Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders

In an opened randomized study of women undergoing in vitro fertilization with expected suboptimal response to controlled ovarian stimulation (Poseidon Group 2b) investigators will examine ...

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

RATIONALE: Epoetin alfa and darbepoetin alfa may cause the body to make more red blood cells. They are used to treat anemia caused by chemotherapy in patients with cancer. PURPOSE: This r...

Companies [26 Associated Companies listed on BioPortfolio]

Alfa Aesar

Since 1963, scientists have relied on Alfa Aesar to supply high purity raw materials for a variety of research and development applications. Today, we are a recognized leader in the manufacture and su...

Alfa Scientific Designs, Inc.

Alfa Scientific Designs, Inc. is a leader in the development and manufacture of rapid, immunoassay, point-of-care tests. As a minority, woman-owned, small business, ALFA offers a ...

Assisted Living Federation of America (ALFA)

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors an...

Alfa Laval

Alfa Laval is a leading global provider of specialized products and engineered solutions. Our equipment, systems and services are dedicated to helping customers to optimize the performance of their pr...

Assisted Living Federation of America

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors and families they serve...

More Information about "Alfa Aesar" on BioPortfolio

We have published hundreds of Alfa Aesar news stories on BioPortfolio along with dozens of Alfa Aesar Clinical Trials and PubMed Articles about Alfa Aesar for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alfa Aesar Companies in our database. You can also find out about relevant Alfa Aesar Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record